Effect of cilostazol on preventing paclitaxel-induced neuropathy in patients with breast cancer: A randomized controlled trial

Paclitaxel-induced peripheral neuropathy is a significant clinical problem can markedly deteriorate patient's quality of life (QoL). Preclinical evidence exists about the preventive capacity of cilostazol against peripheral neuropathy. However, this hypothesis has not yet been clinically invest...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Pharmacotherapy 2023-09, Vol.43 (9), p.872-882
Hauptverfasser:	Haroun, Esraa A, Mansour, Noha O, Eltantawy, Ahmed, Shams, Mohamed E E
Format:	Artikel
Sprache:	eng
Schlagworte:	Breast cancer Cancer therapies Clinical trials Metastases Nerve growth factor Neurotoxicity Oncology Paclitaxel Patients Peripheral neuropathy Placebos Quality of life Serum levels Terminology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!